Hims semaglutide is a subscription telehealth service that includes a clinician visit, a prescription for compounded semaglutide, dispensing through a partner 503A compounding pharmacy, and cold-chain shipping — typically for $199 to $349 per month. The product is legal while branded semaglutide (Ozempic, Wegovy) remains on the FDA shortage list. Compared to branded self-pay pricing of $950 to $1,400, Hims is much cheaper; compared to peers like Henry Meds, Mochi, and Ro, the price is in the middle of the range.
What Hims Includes in the Package
- Online intake questionnaire
- Async or video clinician consultation (US-licensed MD, DO, NP, or PA)
- Prescription for compounded semaglutide at the dose your clinician selects
- Pharmacy fulfillment through a partner 503A compounding pharmacy
- Monthly shipping of pen or vial and syringes (cold-chain)
- Ongoing clinician messaging for dose questions and side-effect management
- Follow-up visits as you titrate
Hers, the female-focused sister brand, is essentially the same program with different marketing and a gender-lens intake flow.
Typical Pricing Ladder
| Plan | Typical Price | What You Get |
|---|---|---|
| Oral semaglutide daily | $199/mo | Oral compounded semaglutide daily tablets or troches |
| Injectable semaglutide (starter) | $249/mo first 3 months | Weekly injectable at 0.25 mg build-up |
| Injectable semaglutide (maintenance) | $299–$349/mo | Weekly injectable at 1.0 mg and above |
| Hims bundle with metformin | $249–$349/mo | Semaglutide plus metformin for insulin-resistant patients |
| Multi-month discount | 10–20% off | Quarterly or annual billing |
Launch promotions often bring the first month below $100. Promotions reset each year, so returning patients should check the current offer.
Who Qualifies
Hims clinicians generally prescribe for:
- BMI ≥ 30
- BMI ≥ 27 with at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, sleep apnea)
- Adults ≥ 18 years
- No disqualifying history — personal or family history of medullary thyroid cancer, multiple endocrine neoplasia 2, severe GI motility disorder, pregnancy, or severe renal or hepatic impairment
The intake is a screening tool, not a substitute for a full endocrine workup. Complex patients should still see an in-person clinician.
How It Compares to Peers
| Service | Monthly Price | Notable Difference |
|---|---|---|
| Hims / Hers | $199–$349 | Brand strength; bundles well with other Hims products |
| Henry Meds | $297–$349 | Flat pricing across titration; direct pharmacy focus |
| Mochi Health | $79 membership + $99–$250 medication | RD-led coaching emphasis |
| Ro Body | $99 first month, $99–$199 ongoing | Co-pay savings card for branded Zepbound also offered |
| Found | $99–$299/mo | Non-GLP-1 option also available |
| Noom Med | $149–$299 | Integrated with Noom weight-loss app |
| Branded Wegovy (self-pay) | $950–$1,400 | FDA-approved product; savings card available for commercial insurance |
| Branded Wegovy (insurance) | $25–$550 | Depends on plan and PA approval |
The Transparency Checklist Before You Order
- Ask which compounding pharmacy fills the prescription (Hims should disclose; some have used Revive Rx, Strive, Empower, Red Rock, and others over time).
- Look up that pharmacy on its home-state pharmacy board website — license active and in good standing?
- Check for any FDA warning letters addressed to the pharmacy.
- Confirm USP 797 sterile-compounding compliance.
- Ask what API source and whether a certificate of analysis is available.
- Confirm the product is semaglutide base, not “semaglutide sodium” or “semaglutide acetate” — the FDA has stated salt forms are not the same drug.
- Confirm cold-chain shipping (ice packs, overnight delivery).
- Ask for the transition plan if the FDA ends the semaglutide shortage.
What to Expect From Treatment
- Weekly injection on the same day, same site rotation (abdomen, thigh, upper arm)
- Nausea, constipation, or fatigue for the first 1 to 2 weeks of each dose bump — usually manageable
- Gradual appetite reduction — typical 10 to 15 percent body weight loss over 6 to 12 months when paired with nutrition and activity
- A1C drop of 1.0 to 1.8 percentage points in type 2 diabetes
- Titration schedule roughly: 0.25 mg week 1–4, 0.5 mg week 5–8, 1.0 mg week 9–12, then to maintenance of 1.7 mg or 2.4 mg
Pros and Cons of Hims Specifically
- Pros: brand recognition, smooth online experience, clear subscription model, wide clinician coverage, multiple product options (oral, injectable, bundled with metformin), promotional first-month pricing
- Cons: self-pay only (no insurance billing), pharmacy partner not always disclosed upfront, compounded supply depends on continuing FDA shortage, relatively transactional clinician relationship
When to Choose an In-Person Clinician Instead
- Existing endocrinologist who already manages your diabetes
- Commercial insurance coverage for branded Wegovy or Ozempic (lower copay than cash on Hims in many cases)
- Complex GI history, chronic kidney disease, prior pancreatitis, or history of medullary thyroid cancer
- Pregnancy or planning pregnancy (GLP-1 agonists not used)
- Eating disorder history that warrants supervised nutrition support
Related Reading
See our broader treatment hub, guides to nutrition while on GLP-1 therapy, and our prediabetes reversal overview for the bigger picture.
The Bottom Line
Hims semaglutide is a mid-priced, brand-name telehealth option that bundles the clinician visit, prescription, compounded pharmacy fulfillment, and shipping for about $199 to $349 per month while the FDA shortage keeps compounding legal. It is cheaper than branded self-pay but more expensive than some peers. Before you sign up, ask for the compounding pharmacy name, verify its state license yourself, confirm it uses semaglutide base (not a salt form), and find out what the plan is when the shortage ends. If you have commercial insurance, also price-compare branded Wegovy with a copay card — sometimes the approved product is competitive after coverage.
